FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Diana Gibb

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Viral Load

Geographic Areas

Physiology

Co-author Network

Publications

TOP 3
Richard Katuramu; Adeodata Kekitiinwa; Peter Mugyenyi; Paula Munderi; Victor Musiime; Philippa Musoke; Patricia Nahirya-Ntege; Bethany Naidoo-James; Kusum Nathoo; Andrew J Prendergast; Margaret Thomason; Constance Tumusiime; Tichaona Vhembo; A Sarah Walker; Sabrina Bakeera-Kitaka; Mutsa Bwakura-Dangarembizi; Adrian Cook; Jane Crawley; Diana M Gibb
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
Kathryn Maitland; Ayub Mpoya; George Mtove; Julius Nteziyaremye; Richard Nyeko; Vicent Okuuny; Peter Olupot-Olupot; Robert O Opoka; Benedict Otii; Natalie Prevatt; Hugh Reyburn; Daniel Semakula; Molline Timbwa; Ronald Wokulira; Samuel O Akech; Abdel G Babiker; Bernadette Brent; Jane Crawley; Cornelius M Dambisya; Ahmed Ddungu; Charles Engoru; Jennifer A Evans; Elizabeth C George; Diana M Gibb; Sarah Kiguli; Michael Levin
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.
Charles F Gilks; Ruth L Goodall; Heiner Grosskurth; James Hakim; Elly Katabira; Cissy Kityo; Peter Mugyenyi; Paula Munderi; Andrew Reid; A Sarah Walker; Diana M Gibb
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Diana Gibb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard Katuramu; Adeodata Kekitiinwa; Peter Mugyenyi; Paula Munderi; Victor Musiime; Philippa Musoke; Patricia Nahirya-Ntege; Bethany Naidoo-James; Kusum Nathoo; Andrew J Prendergast; Margaret Thomason; Constance Tumusiime; Tichaona Vhembo; A Sarah Walker; Sabrina Bakeera-Kitaka; Mutsa Bwakura-Dangarembizi; Adrian Cook; Jane Crawley; Diana M Gibb
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
Lancet 2013;381(9875):1391-403.
2013: Kathryn Maitland; Ayub Mpoya; George Mtove; Julius Nteziyaremye; Richard Nyeko; Vicent Okuuny; Peter Olupot-Olupot; Robert O Opoka; Benedict Otii; Natalie Prevatt; Hugh Reyburn; Daniel Semakula; Molline Timbwa; Ronald Wokulira; Samuel O Akech; Abdel G Babiker; Bernadette Brent; Jane Crawley; Cornelius M Dambisya; Ahmed Ddungu; Charles Engoru; Jennifer A Evans; Elizabeth C George; Diana M Gibb; Sarah Kiguli; Michael Levin
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.
BMC medicine 2013;11():68.
2013: Charles F Gilks; Ruth L Goodall; Heiner Grosskurth; James Hakim; Elly Katabira; Cissy Kityo; Peter Mugyenyi; Paula Munderi; Andrew Reid; A Sarah Walker; Diana M Gibb
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
PloS one 2013;8(2):e57580.
2013: Linda Harrison; Marc Lallemant; Magdalena Marczynska; Antonio Mazza; Maria Jose Mellado Pena; Martina Penazzato; Ana Puga; Jose Tomas Ramos; Osvalda Rampon; Yoann Riault; Jintanat Ananworanich; Torsak Bunupuradah; Hannah Castro; Alexandra Compagnucci; Daniel Floret; Jacquie Flynn; Silvia Forcat; Carlo Giaquinto; Diana M Gibb; Djamel Hamadache
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS and behavior 2013;17(1):193-202.
2012: Julia Kenny; Veronica Mulenga; Francien Scholten; Susan Hoskins; Diana M Gibb
The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low-income and middle-income countries.
AIDS (London, England) 2012;26 Suppl 2():S105-16.
2012: A Sarah Walker; Diana M Gibb; Charles F Gilks; James Hakim; Elly Katabira; Addy Kekitiinwa; Cissy Kityo; Peter Mugyenyi; Paula Munderi; Patricia Nahirya-Ntege; Kusum J Nathoo; Andrew J Prendergast
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(12):1707-18.
2012: Quirine Fillekes; Diana M Gibb; Desiré Kabamba; Chipepo Kankasa; Veronica Mulenga; Margaret J Thomason; A Sarah Walker; Chifumbe Chintu; Adrian Cook; Alex Ferrier; David M Burger
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
AIDS (London, England) 2012;26(14):1795-800.
2012: Barbara Laughton; Shabir A Madhi; Priscilla E Springer; Anita J van Rensburg; Avy Violari; Els Dobbels; Diana M Gibb; Debbie Grove; Patrick Jean-Philippe; Martin Kidd; Abdel G Babiker; Morna Cornell; Mark F Cotton
Early antiretroviral therapy improves neurodevelopmental outcomes in infants.
AIDS (London, England) 2012;26(13):1685-90.
2012: J Mirjam Oudijk; A Sarah Walker; Chifumbe Chintu; Adrian Cook; Diana M Gibb; Helen McIlleron; Concepta Merry; Veronica Mulenga; David M Burger
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
AIDS (London, England) 2012;26(12):1523-8.
2012: Eva P Muro; Rob Schuurman; Andre J A M van der Ven; A Sarah Walker; Wil Dolmans; Quirine Fillekes; Diana M Gibb; Elton R Kisanga; Rafaëlla F A L'homme; Godfrey Mariki; Susan C Aitken; David M Burger
Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
Journal of acquired immune deficiency syndromes (1999) 2012;59(3):266-73.
2012: P Kasirye; Addy Kekitiinwa; L Kendall; T Mhute; P Nahirya-Ntege; W Snowden; M Ssenyonga; C Tumusiime; A Sarah Walker; K K Adkison; Sabrina Bakeera-Kitaka; D M Burger; Diana M Gibb
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
Clinical pharmacology and therapeutics 2012;91(2):272-80.
2012: Charles F Gilks; Pontiano Kaleebu; Ronnie Kasirye; Ben Kikaire; Ivan Mambule; Hellen Musana; Deenan Pillay; Andrew Reid; Val Robertson; Moira Spyer; Francis Ssali; A Sarah Walker; David L Yirrell; David T Dunn; Diana M Gibb
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
Antiviral therapy 2012;17(7):1363-73.
2012: Diana M Gibb; Charles F Gilks; Heiner Grosskurth; James Hakim; Hilda Kizito; Hope Kyomugisha; Paula Munderi; Phillipa Musoke; Ruth Nalumenya; Kusum Nathoo; Elizabeth C Russell; Moira Spyer; Dinah Tumukunde; A Sarah Walker; Eva Zalwango; Ennie Chidziva
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
PLoS medicine 2012;9(5):e1001217.
2012: Katherine L Donegan; David Dunn; Diana M Gibb; Ali Judd; Hermione Lyall; Esse N Menson; Deenan Pillay; Gareth Tudor-Williams; A Sarah Walker
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK.
Antiviral therapy 2012;17(4):599-603.
2011: Rashida A Ferrand; Diana M Gibb; Stanley Mungofa; Kusum Nathoo; Chiratidzo E Ndhlovu; Caroline Trigg; Tsitsi Bandason; Frances M Cowan; Elizabeth L Corbett
Perception of risk of vertically acquired HIV infection and acceptability of provider-initiated testing and counseling among adolescents in Zimbabwe.
American journal of public health 2011;101(12):2325-32.
2011: Andrew Prendergast; A Sarah Walker; Veronica Mulenga; Chifumbe Chintu; Diana M Gibb
Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(7):953-6.
2011: Abdel Babiker; Hannah Castro nee Green; Alexandra Compagnucci; Susan Fiscus; Carlo Giaquinto; Diana M Gibb; Lynda Harper; Linda Harrison; Michael Hughes; Ross McKinney; Ann Melvin; Lynne Mofenson; Yacine Saidi; M Elizabeth Smith; Gareth Tudor-Williams; A Sarah Walker
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
The Lancet infectious diseases 2011;11(4):273-83.
2011: Rashida A Ferrand; Helen A Weiss; Kusum Nathoo; Chiratidzo E Ndhlovu; Stanley Mungofa; Shungu Munyati; Tsitsi Bandason; Diana M Gibb; Elizabeth L Corbett
A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission.
Tropical medicine & international health : TM & IH 2011;16(3):349-55.
2011: A Sarah Walker; Diana M Gibb
Monitoring of highly active antiretroviral therapy in HIV infection.
Current opinion in infectious diseases 2011;24(1):27-33.
2011: Heather B Jaspan; Shabir A Madhi; Landon Myer; Wendy S Stevens; Avy Violari; Els Dobbels; Diana M Gibb; Mark F Cotton
Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study.
BMC pediatrics 2011;11():104.
2011: Wolfgang Stöhr; A Sarah Walker; Diana M Gibb; Charles F Gilks; Heiner Grosskurth; James Hakim; Cissy Kityo; Ivan Mambule; Paula Munderi; Andrew Reid; Francis Ssali
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
Antiviral therapy 2011;16(7):1011-20.
2010: Veronica Mulenga; A Cook; A Sarah Walker; D Kabamba; C Chijoka; A Ferrier; C Kalengo; C Kityo; C Kankasa; David Burger; M Thomason; Chifumbe Chintu; Diana M Gibb
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(9):1081-9.
2010: Rashida A Ferrand; Lucia Munaiwa; John Matsekete; Tsitsi Bandason; Kusum Nathoo; Chiratidzo E Ndhlovu; Shungu Munyati; Frances M Cowan; Diana M Gibb; Elizabeth L Corbett
Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(7):844-51.
2010: Cissy Kityo; A Sarah Walker; L Dickinson; Fredrick Lutwama; J Kayiwa; Francis Ssali; R Nalumenya; D Tumukunde; Paula Munderi; A Reid; Charles F Gilks; Diana M Gibb; Saye Khoo
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.
Antimicrobial agents and chemotherapy 2010;54(7):2965-73.
2010: David Burger; Fiona Ewings; Desiré Kabamba; Rafaëlla F A L'homme; Veronica Mulenga; Chipepo Kankasa; Margaret Thomason; Diana M Gibb; Chifumbe Chintu; A Sarah Walker
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
Therapeutic drug monitoring 2010;32(3):369-72.
2010: K Boyd; David T Dunn; H Castro; Diana M Gibb; Trinh Duong; Jean-Pierre Aboulker; M Bulterys; Mario Cortina Borja; C Gabiano; L Galli; Carlo Giaquinto; D R Harris; M HugheS; R McKinney; L Mofenson; J Moye; M L Newell; Savita Pahwa; P Palumbo; C Rudin; Mike Sharland; W Shearer; B Thompson; Pat A Tookey
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.
AIDS (London, England) 2010;24(8):1213-7.
2010: Paula Munderi; A Sarah Walker; C Kityo; Abdel G Babiker; Francis Ssali; A Reid; Janet Darbyshire; Heiner Grosskurth; Peter Mugyenyi; Diana M Gibb; Charles F Gilks
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
HIV medicine 2010;11(5):334-44.
2010: A Sarah Walker; D Ford; Charles F Gilks; Paula Munderi; F Ssali; A Reid; E Katabira; Heiner Grosskurth; P Mugyenyi; James Hakim; Janet Darbyshire; Diana M Gibb; Abdel G Babiker
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Lancet 2010;375(9722):1278-86.
2010: Rashida A Ferrand; Tsitsi Bandason; Praise Musvaire; Natasha Larke; Kusum Nathoo; Hilda Mujuru; Chiratidzo E Ndhlovu; Shungu Munyati; Frances M Cowan; Diana M Gibb; Elizabeth L Corbett
Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.
PLoS medicine 2010;7(2):e1000178.
2010: Victor Musiime; Lindsay Kendall; Sabrina Bakeera-Kitaka; Wendy B Snowden; Florence Odongo; Margaret Thomason; Philippa Musoke; Kimberly Adkison; David Burger; Peter Mugyenyi; Adeodata Kekitiinwa; Diana M Gibb; A Sarah Walker
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
Antiviral therapy 2010;15(8):1115-24.
2010: Nicaise Ndembi; Nicasie Ndembi; Ruth L Goodall; David T Dunn; Adele McCormick; Andy Burke; Fred Lyagoba; Paula Munderi; Pauline Katundu; Cissy Kityo; Val Robertson; David L Yirrell; A Sarah Walker; Diana M Gibb; Charles F Gilks; Pontiano Kaleebu; Deenan Pillay
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
The Journal of infectious diseases 2010;201(1):106-13.
2009: Caroline Foster; Hermione Lyall; B Olmscheid; G Pearce; S Zhang; Diana M Gibb
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
HIV medicine 2009;10(7):397-406.
2009: Ravindra K Gupta; Diana M Gibb; Deenan Pillay
Management of paediatric HIV-1 resistance.
Current opinion in infectious diseases 2009;22(3):256-63.
2009: Tessa Goetghebuer; Edwige Haelterman; Jerome Le Chenadec; Catherine Dollfus; Diana M Gibb; Ali Judd; Hannah Green; Luisa Galli; Jose Tomas Ramos; Carlo Giaquinto; Josiane Warszawski; Jack Levy
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.
AIDS (London, England) 2009;23(5):597-604.
2009: Caroline Foster; Ali Judd; Pat A Tookey; Gareth Tudor-Williams; David Dunn; Delane Shingadia; Karina Butler; Mike Sharland; Diana M Gibb; Hermione Lyall
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services.
AIDS patient care and STDs 2009;23(3):159-66.
2009: Andrew Riordan; Ali Judd; Katherine Boyd; David Cliff; Katia Doerholt; Hermione Lyall; Esse Menson; Karina Butler; Diana M Gibb
Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland.
The Pediatric infectious disease journal 2009;28(3):204-9.
2009: A Sarah Walker; Deborah Ford; Veronica Mulenga; Margaret J Thomason; Andrew Nunn; Chifumbe Chintu; Diana M Gibb; David R Bangsberg
Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
AIDS and behavior 2009;13(1):33-41.
2008: Addy Kekitiinwa; Katherine J Lee; A Sarah Walker; Albert Maganda; Katja Doerholt; Sabrina B Kitaka; Alice Asiimwe; Ali Judd; Philippa Musoke; Diana M Gibb
Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
Journal of acquired immune deficiency syndromes (1999) 2008;49(4):384-92.
2008: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James McIntyre
Early antiretroviral therapy and mortality among HIV-infected infants.
The New England journal of medicine 2008;359(21):2233-44.
2008: William Burman; Mark F Cotton; Diana M Gibb; A Sarah Walker; Andrew A Vernon; Peter R Donald
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.
PLoS medicine 2008;5(8):e176.
2008: Sylvia K Muyingo; A Sarah Walker; Andy Reid; Paula Munderi; Diana M Gibb; Francis Ssali; Jonathan Levin; Elly Katabira; Charlie Gilks; Jim Todd
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
Journal of acquired immune deficiency syndromes (1999) 2008;48(4):468-75.
2008: Tim R Cressey; Hannah Green; Saye Khoo; Jean-Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M Gibb; David Burger
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(10):1601-8.
2008: Rana Chakraborty; Colette J Smith; David Dunn; Hannah Green; Trinh Duong; Katja Doerholt; Andrew Riordon; Hermione Lyall; Pat A Tookey; Karina Butler; Caroline A Sabin; Diana M Gibb; Deenan Pillay
HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004.
The Pediatric infectious disease journal 2008;27(5):457-9.
2008: Andrew Reid; Wolfgang Stöhr; A Sarah Walker; Ian G Williams; Cissy Kityo; Peter Hughes; Andrew Kambugu; Charles F Gilks; Peter Mugyenyi; Paula Munderi; James Hakim; Diana M Gibb
Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1271-81.
2008: Máirín Ryan; Susan Griffin; Bona Chitah; A Sarah Walker; Veronica Mulenga; Donald Kalolo; Neil Hawkins; Concepta Merry; Michael G Barry; Chifumbe Chintu; Mark J Sculpher; Diana M Gibb
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
AIDS (London, England) 2008;22(6):749-57.
2008: Steven B Welch; Diana M Gibb
When should children with HIV infection be started on antiretroviral therapy?
PLoS medicine 2008;5(3):e73.
2008: Rafaëlla F A L'homme; Desiré Kabamba; Fiona M Ewings; Veronica Mulenga; Chipepo Kankasa; Margaret J Thomason; A Sarah Walker; Chifumbe Chintu; David Burger; Diana M Gibb
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
AIDS (London, England) 2008;22(5):557-65.
2008: David Dunn; Patrick Woodburn; Trinh Duong; Julian Peto; Andrew Phillips; Diana M Gibb; Kholoud Porter
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults.
The Journal of infectious diseases 2008;197(3):398-404.
2007: Ali Judd; Katja Doerholt; Pat A Tookey; Mike Sharland; Andrew Riordan; Esse N Menson; Vas Novelli; E G Hermione Lyall; Janet Masters; Gareth Tudor-Williams; Trinh Duong; Diana M Gibb
Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(7):918-24.
2007: Helen E Harris; Giorgina Mieli-Vergani; Deirdre Kelly; Suzanne Davison; Diana M Gibb; Mary E Ramsay
A national sample of individuals who acquired hepatitis C virus infections in childhood or adolescence: risk factors for advanced disease.
Journal of pediatric gastroenterology and nutrition 2007;45(3):335-41.
2007: Elke H J Krekels; John N van den Anker; Paola Baiardi; Massimo Cella; Katharine Y Cheng; Diana M Gibb; Hannah Green; Achille Iolascon; Evelyne M Jacqz-Aigrain; Catherijne A J Knibbe; Gijs W E Santen; Ron van Schaik; Dick Tibboel; Oscar Della-Pasqua
Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations.
Expert opinion on pharmacotherapy 2007;8(12):1787-99.
2007: A Sarah Walker; Veronica Mulenga; Deborah Ford; Desire Kabamba; Frederick Sinyinza; Chipepo Kankasa; Chifumbe Chintu; Diana M Gibb
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(10):1361-7.
2007: Hannah Green; Diana M Gibb; A Sarah Walker; Deenan Pillay; K Butler; F Candeias; Guido Gattinara Castelli; Alexandra Compagnucci; Marinella Della Negra; Anita De Rossi; C Feiterna-Sperling; Carlo Giaquinto; Lynda Harper; J Levy; Y Saidi; Uwe Wintergerst
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
AIDS (London, England) 2007;21(8):947-55.
2007: Peter L Havens; Diana M Gibb
Increasing antiretroviral drug access for children with HIV infection.
Pediatrics 2007;119(4):838-45.
2007: David Burger; Gwenda Verweel; N Rakhmanina; C P W G M Verwey-Van Wissen; Charles J L la Porte; Alina S Bergshoeff; Hermione Lyall; Nico G Hartwig; Hannah Green; S Soldin; Diana M Gibb; Ronald de Groot
Age-dependent pharmacokinetics of lamivudine in HIV-infected children.
Clinical pharmacology and therapeutics 2007;81(4):517-20.
2007: Ben Kikaire; Saye Khoo; A Sarah Walker; Francis Ssali; Paula Munderi; Letitia Namale; Andrew Reid; Diana M Gibb; Peter Mugyenyi; Heiner Grosskurth
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
AIDS (London, England) 2007;21(6):733-7.
2007: Deborah M Caldwell; Diana M Gibb; Anthony E Ades
Validity of indirect comparisons in meta-analysis.
Lancet 2007;369(9558):270; author reply 271.
2007: Veronica Mulenga; Deborah Ford; A Sarah Walker; Darlington Mwenya; James Mwansa; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Stephen Gillespie; Alimuddin Zumla; Chifumbe Chintu; Diana M Gibb
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
AIDS (London, England) 2007;21(1):77-84.
2007: Hannah Green; Diana M Gibb
Treatment interruption in children with HIV infection.
Current opinion in HIV and AIDS 2007;2(1):62-8.
2007: Katherine J Lee; Delane Shingadia; Deenan Pillay; A Sarah Walker; Andrew Riordan; Esse N Menson; Trinh Duong; Gareth Tudor-Williams; Diana M Gibb
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?
Antiviral therapy 2007;12(6):949-56.
2007: Jane C Ellis; Rafaëlla F A L'homme; Fiona M Ewings; Veronica Mulenga; Frank Bell; Regina Chileshe; Elizabeth Molyneux; Julia Abernethy; Joep J G van Oosterhout; Chifumbe Chintu; A Sarah Walker; Diana M Gibb; David Burger
Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
Antiviral therapy 2007;12(2):253-60.
2007: Rafaëlla F A L'homme; Tim Dijkema; Adilia Warris; Andre J A M van der Ven; Diana M Gibb; David Burger
Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults.
The Journal of antimicrobial chemotherapy 2007;59(1):92-6.
2006: Abdel G Babiker; Diana M Gibb
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patients.
Current opinion in HIV and AIDS 2006;1(6):488-94.
2006: A Sarah Walker; Veronica Mulenga; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Chifumbe Chintu; Diana M Gibb
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
Journal of acquired immune deficiency syndromes (1999) 2006;42(5):637-45.
2006: Marthe LePrevost; Hannah Green; Jacquie Flynn; Stephen Head; Margaret Clapson; Hermione Lyall; Vas Novelli; Laura Farrelly; A Sarah Walker; David Burger; Diana M Gibb
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.
The Pediatric infectious disease journal 2006;25(6):533-7.
2006: Esse N Menson; A Sarah Walker; Mike Sharland; Carole Wells; Gareth Tudor-Williams; F Andrew I Riordan; E G Hermione Lyall; Diana M Gibb
Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.
BMJ (Clinical research ed.) 2006;332(7551):1183-7.
2006: Katja Doerholt; Trinh Duong; Pat A Tookey; Karina Butler; Hermione Lyall; Mike Sharland; Vas Novelli; Andrew Riordan; David Dunn; A Sarah Walker; Diana M Gibb
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.
The Pediatric infectious disease journal 2006;25(5):420-6.
2006: Francis Ssali; Wolfgang Stöhr; Paula Munderi; Andrew Reid; A Sarah Walker; Diana M Gibb; Peter Mugyenyi; Cissy Kityo; Heiner Grosskurth; James Hakim; Helen Byakwaga; Elly Katabira; Janet Darbyshire; Charles F Gilks
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Antiviral therapy 2006;11(6):741-9.
2006: Hannah Green; Diana M Gibb; Alexandra Compagnucci; Vania Giacomet; Anita De Rossi; Lynda Harper; Yacine Saïdi; Guido Gattinara Castelli; Deenan Pillay; Abdel G Babiker; Jean-Pierre Aboulker; Hermione Lyall; Lee Bacheler; A Sarah Walker; Marianne Debré; Raffaella Rosso; David Burger; Marinella Della Negra; David T Dunn; Carlo Giaquinto
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
Antiviral therapy 2006;11(7):857-67.
2005: Marietta Charakida; Ann E Donald; Hannah Green; Clare Storry; Margaret Clapson; Muriel J Caslake; David T Dunn; julian halcox; Diana M Gibb; Nigel J Klein; John E Deanfield
Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.
Circulation 2005;112(1):103-9.
2005: Alina S Bergshoeff; David Burger; Corrien Verweij; Laura Farrelly; Jacquie Flynn; Marthe Le Prevost; Sarah Walker; Vas Novelli; Hermione Lyall; Saye Khoo; Diana M Gibb
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13).
Antiviral therapy 2005;10(2):239-46.
2005: Anita De Rossi; A Sarah Walker; Davide De Forni; Nigel Klein; Diana M Gibb
Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
Antiviral therapy 2005;10(1):63-71.
2004: Esse N Menson; A Sarah Walker; Diana M Gibb
Clinical trials in children.
Lancet 2004;364(9452):2176-7.
2004: Chifumbe Chintu; G J Bhat; A Sarah Walker; Veronica Mulenga; Frederick Sinyinza; Kennedy Lishimpi; Laura Farrelly; N Kaganson; Alimuddin Zumla; S H Gillespie; Andrew Nunn; Diana M Gibb
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Lancet 2004;364(9448):1865-71.
2004: E Randall Lanier; N Givens; Chris Stone; Philip Griffin; Diana M Gibb; S Walker; Margaret Tisdale; David Irlbeck; M Underwood; Marty St Clair; Mounir Ait-Khaled
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens.
HIV medicine 2004;5(6):394-9.
2004: David T Dunn; Diana M Gibb; Abdel G Babiker; Hannah Green; Janet Darbyshire; I V D Weller
HIV drug resistance testing: is the evidence really there?
Antiviral therapy 2004;9(5):641-8.
2004: A Sarah Walker; Katja Doerholt; Mike Sharland; Diana M Gibb
Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
AIDS (London, England) 2004;18(14):1915-24.
2004: David Burger; Alina S Bergshoeff; Ronald de Groot; Diana M Gibb; Sarah Walker; Jean-Marc Tréluyer; Richard Hoetelmans
Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
The Journal of pediatrics 2004;145(3):403-5.
2004: Mike Sharland; S Blanche; G Castelli; J Ramos; Diana M Gibb
PENTA guidelines for the use of antiretroviral therapy, 2004.
HIV medicine 2004;5 Suppl 2():61-86.
2004: Diana M Gibb; Trinh Duong; Veronica A Leclezio; A Sarah Walker; Gwenda Verweel; David T Dunn
Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
The Pediatric infectious disease journal 2004;23(5):446-50.
2004: Jean-Pierre Aboulker; Abdel G Babiker; Marie-Laure Chaix; Alexandra Compagnucci; Janet Darbyshire; M Debré; Albert Faye; Carlo Giaquinto; Diana M Gibb; Lynda Harper; Yacine Saïdi; A Sarah Walker
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.
AIDS (London, England) 2004;18(2):237-45.
2003: Diana M Gibb; T Duong; Pat A Tookey; Mike Sharland; Gareth Tudor-Williams; Vas Novelli; Karina Butler; Andrew Riordan; Laura Farrelly; Janet Masters; Catherine Peckham; David T Dunn
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.
BMJ (Clinical research ed.) 2003;327(7422):1019.
2003: Gwenda Verweel; Mike Sharland; Hermione Lyall; Vas Novelli; Diana M Gibb; Gillian Dumont; Colin Ball; Ed Wilkins; Sam Walters; Gareth Tudor-Williams
Nevirapine use in HIV-1-infected children.
AIDS (London, England) 2003;17(11):1639-47.
2003: Mike Sharland; Diana M Gibb; Gareth Tudor-Williams
Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.
Sexually transmitted infections 2003;79(1):53-5.
2003: Diana M Gibb; Ruth L Goodall; Vania Giacomet; Laura McGee; Alexandra Compagnucci; Hermione Lyall
Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.
The Pediatric infectious disease journal 2003;22(1):56-62.
2003: Catherine Litalien; Albert Faye; Alexandra Compagnucci; Carlo Giaquinto; Lynda Harper; Diana M Gibb; Evelyne Jacqz-Aigrain
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
The Pediatric infectious disease journal 2003;22(1):48-55.
2002: Diana M Gibb; A Sarah Walker; Steve Kaye; Anita De Rossi; Mounir Ait-Khaled; Deenan Pillay; Maria Angeles Muñoz-Fernandez; Clive Loveday; Alexandra Compagnucci; David T Dunn; Abdel G Babiker
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Antiviral therapy 2002;7(4):293-303.
2002: Anita De Rossi; A Sarah Walker; Davide De Forni; Diana M Gibb
Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
AIDS (London, England) 2002;16(14):1961-3.
2002: Deenan Pillay; A Sarah Walker; Diana M Gibb; Anita De Rossi; Steve Kaye; Mounir Ait-Khaled; Maria Muñoz-Fernandez; Abdel G Babiker
Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial.
The Journal of infectious diseases 2002;186(5):617-25.
2002: Mike Sharland; Diana M Gibb; Gareth Tudor-Williams
Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom.
Archives of disease in childhood 2002;87(3):178-80.
2002: Anita De Rossi; A Sarah Walker; Nigel Klein; Davide De Forni; Doug King; Diana M Gibb
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
The Journal of infectious diseases 2002;186(3):312-20.
2002: Mike Sharland; G Castelli Gattinara di Zub; J Tomas Ramos; S Blanche; Diana M Gibb
PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.
HIV medicine 2002;3(3):215-26.
2002: Simon Nadel; Quen Mok; Allan Goldman; Diana M Gibb
Albumin and hypovolaemia.
Lancet 2002;359(9318):1698.
2002: Stephen M Graham; Diana M Gibb
HIV disease and respiratory infection in children.
British medical bulletin 2002;61():133-50.
2001: S M Yeung; Diana M Gibb
Paediatric HIV infection--diagnostic and epidemiological aspects.
International journal of STD & AIDS 2001;12(9):549-54.
2001: A Sarah Walker; Abdel G Babiker; Diana M Gibb; David T Dunn
Mother-to-child transmission of HIV-1 and infant feeding practice.
AIDS (London, England) 2001;15(10):1327-8.
2001: David T Dunn; Diana M Gibb; M Healy; Ruth L Goodall; Karina Butler; M Cafferkey; PE Neave
Timing and interpretation of tests for diagnosing perinatally acquired hepatitis C virus infection.
The Pediatric infectious disease journal 2001;20(7):715-6.
2001: A J Williams; Trinh Duong; lisa mcnally; Pat A Tookey; Janet Masters; R Miller; E G Hermione Lyall; Diana M Gibb
Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection.
AIDS (London, England) 2001;15(3):335-9.
2000: Diana M Gibb; Carlo Giaquinto
Children with HIV infection: special cases.
Lancet 2000;356 Suppl():s34.
2000: Diana M Gibb; Ruth L Goodall; David T Dunn; M Healy; PE Neave; M Cafferkey; Karina Butler
Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission.
Lancet 2000;356(9233):904-7.
2000: Anthony E Ades; Julie Ratcliffe; Diana M Gibb; Mark J Sculpher
Economic issues in the prevention of vertical transmission of HIV.
PharmacoEconomics 2000;18(1):9-22.
2000: Diana M Gibb; A Newberry; N Klein; A de Rossi; ilse grosch-woerner; A Babiker
Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.
Lancet 2000;355(9212):1331-2.
2000: Diana M Gibb; PE Neave; Pat A Tookey; Mary Ramsay; H Harris; Koye Balogun; D Goldberg; G Mieli-Vergani; D Kelly
Active surveillance of hepatitis C infection in the UK and Ireland.
Archives of disease in childhood 2000;82(4):286-91.
2000: Diana M Gibb
Antenatal screening for HIV infection.
AIDS patient care and STDs 2000;14(3):125-31.
1999: Anthony E Ades; Mark J Sculpher; Diana M Gibb; R Gupta; Julie Ratcliffe
Cost effectiveness analysis of antenatal HIV screening in United Kingdom.
BMJ (Clinical research ed.) 1999;319(7219):1230-4.
1999: T Duong; Anthony E Ades; Diana M Gibb; Pat A Tookey; Janet Masters
Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data.
BMJ (Clinical research ed.) 1999;319(7219):1227-9.
1999: Diana M Gibb; Anthony E Ades; R Gupta; Mark J Sculpher
Costs and benefits to the mother of antenatal HIV testing: estimates from simulation modelling.
AIDS (London, England) 1999;13(12):1569-76.
1999: Anthony E Ades; R Gupta; Diana M Gibb; Trinh Duong; A Nicoll; D Goldberg; J Stephenson; A Copas
Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice.
AIDS (London, England) 1999;13(2):271-8.
1999: Diana M Gibb; B H Tess
Interventions to reduce mother-to-child transmission of HIV infection: new developments and current controversies.
AIDS (London, England) 1999;13 Suppl A():S93-102.
1998: Julie Ratcliffe; Anthony E Ades; Diana M Gibb; Mark J Sculpher; Andrew H Briggs
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness.
AIDS (London, England) 1998;12(11):1381-8.
1998: Mark J Sculpher; Diana M Gibb; Anthony E Ades; Julie Ratcliffe; Trinh Duong
Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers.
AIDS (London, England) 1998;12(11):1371-80.
1998: Helen Bedford; R Booy; D Dunn; Carolyn DiGuiseppi; Diana M Gibb; Ruth Gilbert; Stuart Logan; Catherine Peckham; Ian Roberts; Pat A Tookey
Autism, inflammatory bowel disease, and MMR vaccine.
Lancet 1998;351(9106):907; author reply 908-9.
1998: Diana M Gibb; S E MacDonagh; R Gupta; Pat A Tookey; Catherine Peckham; Anthony E Ades
Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study.
BMJ (Clinical research ed.) 1998;316(7127):259-61.
1998: Pat A Tookey; Diana M Gibb; T Ades
Performance of antenatal HIV screening strategies in the UK: correction.
Journal of medical screening 1998;5(4):214.
1998: Diana M Gibb
Reduction of mother-to-child transmission of HIV infection: non-pharmaceutical interventions and their implementation.
International journal of STD & AIDS 1998;9 Suppl 1():19-21.
1998: Pat A Tookey; Diana M Gibb; Anthony E Ades; Trinh Duong; Janet Masters; Lorraine Sherr; Catherine Peckham; CN Hudson
Performance of antenatal HIV screening strategies in the United Kingdom.
Journal of medical screening 1998;5(3):133-6.
1997: Diana M Gibb; Janet Masters; Delane Shingadia; S Trickett; N Klein; C Duggan; Vas Novelli; D Mercey
A family clinic--optimising care for HIV infected children and their families.
Archives of disease in childhood 1997;77(6):478-82.
1997: Diana M Gibb; S E MacDonagh; Pat A Tookey; Trinh Duong; A Nicoll; D J Goldberg; CN Hudson; Catherine Peckham; Anthony E Ades
Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland.
AIDS (London, England) 1997;11(7):F53-8.
1997: M Sharland; Diana M Gibb; F Holland
Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection.
Archives of disease in childhood 1997;76(4):334-6.
1997: J A Evans; Diana M Gibb; F J Holland; Pat A Tookey; J Pritchard; Anthony E Ades
Malignancies in UK children with HIV infection acquired from mother to child transmission.
Archives of disease in childhood 1997;76(4):330-3.
1997: Mike Sharland; Diana M Gibb; Gareth Tudor-Williams; Sam Walters; Vas Novelli
Paediatric HIV infection.
Archives of disease in childhood 1997;76(4):293-6.
1997: Diana M Gibb; M L Brown
Really understanding the cardiotocograph (CTG).
Professional care of mother and child 1997;7(5):125-8.
1996: Diana M Gibb; A Giacomelli; Janet Masters; V Spoulou; E Ruga; H Griffiths; S Kroll; Carlo Giaquinto; David Goldblatt
Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
The Pediatric infectious disease journal 1996;15(12):1097-101.
1996: R A Solèr; M Howard; Nicola S Brink; Diana M Gibb; Richard S Tedder; D Nadal
Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(3):501-3; discussion 504-5.
1996: S E MacDonagh; Janet Masters; B A Helps; Pat A Tookey; Anthony E Ades; Diana M Gibb
Descriptive survey of antenatal HIV testing in London: policy, uptake, and detection.
BMJ (Clinical research ed.) 1996;313(7056):532-3.
1995: Catherine Peckham; Diana M Gibb
Mother-to-child transmission of the human immunodeficiency virus.
The New England journal of medicine 1995;333(5):298-302.
1995: Diana M Gibb; W Faulknall; L Nokes; S Appleby; F J Holland; T Berry; Anthony E Ades
Coverage of routine neonatal metabolic screening in children born to women known to be infected with HIV-1.
Communicable disease report. CDR review 1995;5(8):R123-4.
1995: Diana M Gibb; M Barry; S Ormesher; L Nokes; M Seefried; Carlo Giaquinto; David Back
Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
British journal of clinical pharmacology 1995;39(5):527-30.
1995: Diana M Gibb; J H Darbyshire; M Debré; C Giaquinto; J P Aboulker; M Martinez; G Tudor-Williams
Treatment of children with HIV infection. PENTA (Paediatric European Network for Treatment of AIDS)
Lancet 1995;345(8957):1115.
1995: M L Newell; Diana M Gibb
A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.
Drug safety : an international journal of medical toxicology and drug experience 1995;12(4):274-82.
1995: Diana M Gibb; V Spoülou; A Giacomelli; H Griffiths; Janet Masters; S Misbah; L Nokes; A Pagliaro; Carlo Giaquinto; S Kroll
Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection.
The Pediatric infectious disease journal 1995;14(2):129-35.
1994: Diana M Gibb; C F Davison; F J Holland; S Walters; Vas Novelli; J Mok
Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles.
Archives of disease in childhood 1994;70(3):241-4.
1994: Diana M Gibb; P W Soothill; K J Ward
Conservative management of placenta accreta.
British journal of obstetrics and gynaecology 1994;101(1):79-80.
1993: Anthony E Ades; C F Davison; F J Holland; Diana M Gibb; CN Hudson; A Nicholl; D Goldberg; Catherine Peckham
Vertically transmitted HIV infection in the British Isles.
BMJ (Clinical research ed.) 1993;306(6888):1296-9.
1992: R M Beattie; J Q Trounce; E G Lyall; Diana M Gibb
Early thrombocytopenia in HIV infection.
Archives of disease in childhood 1992;67(9):1093-4.
1992: Diana M Gibb; M L Newell
HIV infection in children: epidemiological and diagnostic aspects.
International journal of STD & AIDS 1992;3(4):235-8.
1992: Diana M Gibb; Marie-Louise Newell
HIV infection in children.
Archives of disease in childhood 1992;67(1):138-41.
1991: M G Long; Diana M Gibb; S Kempley; Linda Cardozo; K Nicolaides; H Gamsu
Retention of the second twin: a viable option? Case reports.
British journal of obstetrics and gynaecology 1991;98(12):1295-9.
1991: Diana M Gibb; C Duggan; R Lwin
The family and HIV.
Genitourinary medicine 1991;67(5):363-6.
1991: Diana M Gibb
Kawasaki disease: a disorder looking for an organism?
Paediatric and perinatal epidemiology 1991;5(2):123-32.
1990: Diana M Gibb; A B Foot; B May; H Parish; S Strang; D B Grant; David D Dunger
Human isophane or lente insulin? A double blind crossover trial in insulin dependent diabetes mellitus.
Archives of disease in childhood 1990;65(12):1334-7.
1990: Diana M Gibb; David D Dunger; Michael Levin; D Grant; P Jones; TM Barratt
Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.
Archives of disease in childhood 1990;65(1):93-8.
1989: Diana M Gibb; Vanita Shah; M Preece; TM Barratt
Variability of urine albumin excretion in normal and diabetic children.
Pediatric nephrology (Berlin, Germany) 1989;3(4):414-9.
1989: Diana M Gibb; David D Dunger; Michael Levin; Vanita Shah; C Smith; TM Barratt
Early markers of the renal complications of insulin dependent diabetes mellitus.
Archives of disease in childhood 1989;64(7):984-91.
1989: Diana M Gibb; N R Dalton; M T Barratt
Measurement of glomerular filtration rate in children with insulin-dependent diabetes mellitus.
Clinica chimica acta; international journal of clinical chemistry 1989;182(2):131-9.
1989: Diana M Gibb; P A Tomlinson; N R Dalton; C Turner; Vanita Shah; TM Barratt
Renal tubular proteinuria and microalbuminuria in diabetic patients.
Archives of disease in childhood 1989;64(1):129-34.
1989: Diana M Gibb; M Levin; C Smith; T M Barratt
Red cell surface charge and urine albumin excretion in children with insulin-dependent diabetes mellitus.
Nephron 1989;51(4):563-4.